Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Clinical trial NCT06581432 · RECRUITING
Trial details
- NCT number
- NCT06581432
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-11
- Primary completion
- 2028-11-30
- Enrollment
- 588
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.